Founded in 1956, Zhejiang Sea is Pharmaceutical Company Limited (stock code 600 267, hereinafter referred to as "the sea is medicine"), adhering to the "persistent drug innovation, achievement healthy Dream" mission and "became widely respected global pharmaceutical companies," the vision, commitment on the integration of drug development and production resources for global customers with better products and services through the U.S. FDA, EU EDQM, Australian TGA, such as South Korea KFDA official certification to more than 40 varieties, sold more than 30 countries and regions .
2009, the company won the "National Labor Award", the sea is, HISUN and graphics are recognized as "China Famous Brand", named "China's ten thousand kinds of microbial genome plan "and" major national (lb) class of drug varieties industrial Innovation Alliance. " Due to the successful completion of "A stream of drug intermediates, anti-production" of national task orders by the provincial government awards.
2010, the company named Zhejiang Province, the pharmaceutical industry "top ten enterprises," and won the "Best Product Line Top Ten domestic industrial enterprises", and was as the "Golden Bee Award for growth companies"; the same year, the company achieved sales of 4.5 billion, total profit of 450 million yuan, respectively, over the same period last year 14.4%and 28.2%.